Hemogenyx Pharmaceuticals Share Discussion Threads

[purple11] 27/4/2020 08:25

SILENCE FROM DAVET

[purple11] 27/4/2020 08:24

2.65 TO SELL

DAVET doing his nut

[purple11] 27/4/2020 08:23

2.55 TO SELL

POOR DAVET

[dave4545] 27/4/2020 08:22

Breaking out nicely this morning

[purple11] 27/4/2020 08:22

2.60 on the ask davet

THE FEAR OF MISSING OUT

[asat91] 26/4/2020 19:08

Although I really liked Statler and Waldorf, no muppet was ever superior.

[davevt] 26/4/2020 11:18

And I'm sure Einstein learned from his mistakes...the Muppets on here don't and try to encourage others to make the same mistakes.

[bunz3] 25/4/2020 14:11

for holders of ncyt Bulgarian posting now
have never seen that poster posting have read in posts how good at trying to buy into shares just before news

[on target] 24/4/2020 20:44

Einstein didn't swan around telling everyone he was always right though did he?

[asat91] 24/4/2020 19:18

When we argue with others online for points we waste time that could have been spent improving our own station.

Everyone gets things wrong. Einstein made thousands of mistakes in his lifetime, more mistakes than most people because he was willing to try more things than most do without a fear of failure.

[chinadog3] 24/4/2020 18:08

Kathyy just move on from this share. You are not doing yourself any good wringing your hands like this.

By the bye you asked me to retain a post you made two days ago. You said you would be proved right on your prediction after the RNS. Sad to say you were wrong.

Best

[davevt] 24/4/2020 17:01

nope, shifted £4.2k at 2.2.

Highest sell today 2.3 for similar volume, then dropping to 2.2s at the end of the day.

See, told you.

Poor purple thought it was gonna rocket ship! Don't know why he would want to, thought he was now a wannabe 'trader' 😂

I'm here all week 😂😂😂

[tullynessle] 24/4/2020 16:36

Additional to Post 1684

Can we assume that the potential application mentioned in the Hemogenyx RNS dated 22/04/2020, and copied at Extract 2 in Post 1684, is the same as the application mentioned in the Hemogenyx RNS dated 24 June 2019 and copied at Extract below.

I suspect that the answer is "yes", in which case Hemogenyx may have been contemplating / researching the issue for the past eleven (11) months.

If this is the case then considerable progress may have been achieved already?



Extract:

"The Directors also believe that the ApbHC could potentially be used as a tool for the rapid development and/or isolation of human antibodies against unknown human-specific pathogens (biodefense applications)."





Hemogenyx - RNS

Hemogenyx Pharmaceuticals PLC Development of ApbHC
24/06/2019

Development of ApbHC, a Novel Type of Humanized Mouse

Hemogenyx Pharmaceuticals plc (LSE: HEMO) announces that its wholly owned subsidiary Immugenyx, LLC ("Immugenyx") has developed an Advanced peripheral blood Hematopoietic Chimera ("ApbHC"), a novel type of humanized mouse that presents several advantages over other mouse models. Immugenyx was established by the Company to develop and commercialise the Company's Advanced Hematopoietic Chimeras (AHC) or humanized mice and the new ApbHC represents a significant further development in that direction.

As with AHC, the Company believes that the ApbHC will be of considerable interest to other drug developers and initial interest shown is promising.

RNS continues....

[dave4545] 24/4/2020 16:25

2.15p bid on monitor 2.25p online very strong

[tullynessle] 24/4/2020 16:14

Hemogenyx provide details of two potential applications for their ApbHC humanized mice and other in-house technology, noting that this " development is an application of the Company's existing work, taking place alongside its long-term development of new treatments for blood and autoimmune diseases, which remain on track."


Extract 1:

With the outbreak of COVID-19, the Company concluded that it would potentially be applicable to the SARS-CoV-2 virus. As part of its studies, Hemogenyx will transplant cells from blood samples from patients who are either recovering or have already recovered from COVID-19 into its ApbHC humanized mice. The process will allow the Company's scientists to recreate a set of anti-SARS-CoV-2 virus antibodies which could be used for the treatment of COVID-19.


Extract 2:

"In addition, the study will aim to demonstrate how Hemogenyx's technology can be deployed rapidly in emergencies in order to discover human neutralizing antibodies against a host of viral pathogens, including what infectious disease experts in the bioprotection and biodefense sectors call "Disease X", meaning as-yet unknown viruses that may represent a similar or greater threat than the one presented by COVID-19."





Hemogenyx - RNS

Hemogenyx Pharmaceuticals PLC COVID-19 Project Initiated
22/04/2020 11:00am

Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for deadly blood diseases, is deploying its groundbreaking research and technologies to develop potential treatments for COVID-19.

Using its humanized mice, the Advanced peripheral blood Hematopoietic Chimera ("ApbHC"), which were developed to model blood and autoimmune diseases and to test treatments, Hemogenyx will seek to discover human neutralizing antibodies - antibodies that are typically developed by the human immune system to neutralize invading viral pathogens - that could be used to fight SARS-CoV-2 (the virus that causes COVID-19) infections.

RNS continues......

[knowing] 24/4/2020 15:32

Not another one with a premature sale

[purple11] 24/4/2020 15:20

bid is 2.35

THE FEAR OF MISSING OUT

[johntopdog] 24/4/2020 15:01

Davevt suffering from FOMO

Maybe domestos Dave has injected himself with bleach and is sitting in the sunshine hoping he has cured himself 😂😂

[jibba jabber] 24/4/2020 14:54

I look forward to selling out at around 1.50 end of May, i will be a multi millionaire at 1.50